期刊文献+

手术切除结合术后间质内放化疗治疗脑恶性胶质瘤 被引量:3

Interstitial radiotherapy combined with chemotherapy for postoperative malignant gliomas
下载PDF
导出
摘要 目的探讨脑恶性胶质瘤切除术后结合间质内放疗并问质内化疗的临床疗效。方法 32例脑恶性胶质瘤均行显微神经外科手术全切除或次全切除,术中根据术前计算机三维治疗计划系统(TPS)在瘤床上植入^(125)I放射性粒子行组织问持续内照射,总量为50~60 Gy,同时于瘤腔内放置Ommagy化疗囊,术后1周开始应用盐酸尼莫司汀(ACNU)行间质化疗,每周1次,连续6周。随访观察肿瘤复发率、患者生存率、中位生存期。结果 32例患者1、2年复发率分别为31.2%、68.8%,1、2、5年生存率分别为94.3%、80.6%、29.1%,中位生存期为92.3周;无明显放疗、化疗并发症。结论在手术力争全切除肿瘤基础上结合术后间质内放疗、化疗治疗脑恶性胶质瘤,疗效较好,安全而且并发症少。 Objective To investigate curative effects of interstitial radiotherapy combined with of interstitial chemotherapy on the postoperative malignant gliomas. Methods 32 patients with malignant gliomas underwent total resection or subtotal resection. ^125 I radioactive particles were implanted in the tumor bed intraoperatively to give internal irradiation in accordance with preoperative three-dimensional computer treatment planning system ( TPS), total amount of 50 60Gy. Meanwhile the Ommagy sac were placed, and Nimustine Hydrochloride (ACNU) were used in interstitial chemotherapy one week later,lasted for 6 weeks. Follow:up observation included the rate of tumor recurrence, patient survival and the median survival time. Results Recurrence rates of 1 and 2 years were 31.2% and 68.8% ,survival rates of 1,2 and 5 years were 94.3% ,80.6% and 29.1%, with a median survival time was 92. 3 weeks, without radiotherapy and chemotherapy complications. Conclusion The curative effect of interstitial radiotherapy combined with interstitial chemotherapy on the postoperative glioma is good with safe and fewer complications.
出处 《临床神经外科杂志》 CAS 2010年第2期98-99,共2页 Journal of Clinical Neurosurgery
关键词 脑胶质瘤 ~125I放射性粒子 间质放疗 间质化疗 glioma ^125I radioactive particles interstitial radiotherapy interstitial chemotherapy
  • 相关文献

参考文献13

  • 1程敬民,顾建文,屈延,匡永勤,杨立斌,马原,程林,杨文涛.手术切除联合放射性粒子永久性植入治疗复发性胶质瘤[J].临床神经外科杂志,2008,5(4):179-181. 被引量:8
  • 2白刚,罗林.脑胶质瘤的手术后化疗[J].云南医药,2006,27(4):405-408. 被引量:7
  • 3顾科,张军宁.脑胶质瘤放化疗研究进展[J].实用癌症杂志,2005,20(6):665-667. 被引量:13
  • 4邰军利,李安民,傅相平,张志文,闫润民,查炜光.手术联合瘤内近距离放射治疗复发性胶质瘤[J].临床神经外科杂志,2008,5(1):35-36. 被引量:6
  • 5Stewart LA.Chemotherapy in adult high grade glioma:asystematic review and meta analysis of individual patient data from 12randomised trials[J].Lancet,2002,359:1011.
  • 6Shibamoto Y,Kitakabu Y,Takahashi M,et al:su-pratentorial LowGrade Astrocytoma,Correlation of Computed Tomogrophy Findings With Effect of Radiation Therapy and Prognostic Variables.Cancer1993,72:190.
  • 7Curran WJ Jr,Scott CB,Horton J,et al.Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials[J].J Natl Cancer lnst,1993,85:704.
  • 8Buckner JC.Factors influencing survival in high grade gliomas[J].Semin Oncol,2003,30:10.
  • 9DeAngelis LM.Brain tumors[J].N Engl J Med,2001,344:114.
  • 10Michael FB,Emily LLA,Wai-Hoe N,et al.Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma[J].Ann Acad Med Singapore,2007,6:347.

二级参考文献61

  • 1王明盛,杨正明,陈坚.卡铂、威猛、甲氨蝶呤、尼莫地平联用对脑胶质瘤的抑制作用[J].山东医药,2005,45(10):22-23. 被引量:5
  • 2金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 3张蕈林.抗肿瘤药物的药理与临床应用[M].郑州:河南医科大学出版社,1999.230-234.
  • 4[1]Mayr MT,Crocker IR,Butker EK,et al.Results of brachytherapy for malignant brain tumors[J].Int J Oncol.2002,21:817.
  • 5[2]Melnyk O,Shuman MA,Kim KJ,et a1.Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth[J].Cancer Res.1996,56:921.
  • 6[3]Takano S,Kamiyama H,Tsuboi K,Matsumura A,et al.Angiogenesis and antiangiogenic therapy for malignant gliomas[J].Brain Tumor Pathol.2004,21:69.
  • 7[5]Harsh G R,Levin V A,Gutin P H,et al.Reoperation for recurrent glioblastoma and anaplastic astrocytoma[J].Neurosurgery.1987,21:615.
  • 8[6]Ammirati M,Galicich J H,Arbit E,et al.Reoperation in the treatment of recurrent intracranial malignant gliomas[J].Neurosurgery.1987,21:607.
  • 9[8]Gutin P H,Prados M D,Phillips T L,et al.External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas:NCOG Study 6G-82-2[J].Int J Radiation Oncology Biol Phys,1991;21:601..
  • 10[9]Tatter SB,Shaw EG,Rosenblum ML,et al.An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma:multicenter safety and feasibility trial[J].Neurosurgery,2003,99:297.

共引文献36

同被引文献20

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部